New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 10, 2014
11:51 EDTCMG, AZN, ISRG, SNDK, AKAMOptions with increasing implied volatility: AKAM ISRG CMG SNDK AZN
News For AKAM;ISRG;CMG;SNDK;AZN From The Last 14 Days
Check below for free stories on AKAM;ISRG;CMG;SNDK;AZN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
April 8, 2014
16:53 EDTISRGIntuitive Surgical sees Q1 da Vinci Surgical Systems revenue down 59%
Subscribe for More Information
16:50 EDTISRGIntuitive Surgical down over 12% following weak Q1 revenue forecast
16:49 EDTISRGIntuitive Surgical sees Q1 revenue $465M, consensus $537.9M
Subscribe for More Information
16:48 EDTISRGIntuitive Surgical sees Q1 pre-tax charge $67M related to legal claims
Subscribe for More Information
16:46 EDTISRGIntuitive Surgical sees Q1 revenue $465M, consensus $537.9M
16:21 EDTISRGIntuitive Surgical initiated with an Underperform at Sterne Agee
Sterne Agee views Intuitive Surgical shares as overvalued and thinks consensus revenue estimates for 2014 and 2015 may be too high. The firm does not think many hospitals will purchase new da Vinci systems for laparoscopic cholecystectomy procedures. It initiated shares of Intuitive Surgical with an Underperform rating and $440 price target.
11:27 EDTAKAMOptions with increasing implied volatility: PBR AKAM WDAY EXPE
11:03 EDTAZNPiper Jaffray's biopharm analyst holds an analyst/industry conference call
Biopharm Analyst Schimmer discusses PCSK9 Inhibitors and other atherosclerosis approaches on an Analyst/Industry conference call. Relevant companies AEGR, ALNY, AMGN, ARNA, AZN, BMY, CBST, LLY, ESPR, GSK, ICPT, ISIS, MNKD, MRK, OREX, PFE, REGN, RHHBY, SNY and VVUS may be included on the Analyst/Industry conference call to be held on April 10 at 3 pm.
09:44 EDTISRGDoctors upset over Intuitive system's lack of interoperability, TheStreet says
The doctors and hospitals "expected to pay for and use" the new da Vinci Xi systems recently launched by Intuitive Surgical are upset over the way the launch was handled and the fact that the new system does not work with their existing prior generation da Vinci robots, said Benjamin Davies, MD, in a report published by TheStreet. Reference Link
April 7, 2014
16:34 EDTAZNMyriad Genetics submits premarket approval to FDA for BRACAnalysis
Subscribe for More Information
13:05 EDTSNDKAnalyst says semiconductor stocks attractive after decline
Subscribe for More Information
11:49 EDTAKAMOptions with increasing implied volatility: PBR AKAM HST L
Subscribe for More Information
10:13 EDTCMGChipotle Mexican Grill volatility elevated into Q1 and outlook
Subscribe for More Information
08:16 EDTSNDKPullback in semiconductor stocks creates buying opportunity, says Sterne Agee
After many semiconductor stocks dropped significantly on Friday, Sterne Agee thinks that the group's fundamental mid to long-term outlook hasn't changed. Sterne Agee thinks the companies are poised to benefit from strong product cycles and earnings leverage. It is most upbeat on Micron (MU), NXP Semiconductors (NXPI), Avago (AVGO), Skyworks (SWKS), and SanDisk (SNDK). The firm keeps Buy ratings on all the stocks named.
07:34 EDTISRGIntuitive Surgical price target raised to $595 from $480 at Jefferies
Subscribe for More Information
07:29 EDTISRGIntuitive Surgical price target raised to $550 from $420 at Leerink
Subscribe for More Information
07:27 EDTAZNAmerican Association of Cancer Research to hold annual meeting
Subscribe for More Information
05:48 EDTAZNMyriad Genetics submits premarket approval to FDA for BRACAnalysis
Subscribe for More Information
April 4, 2014
12:31 EDTISRGIntuitive Surgical price target raised to $650 from $550 at Barrington
Subscribe for More Information
06:51 EDTISRGIntuitive Surgical new robot a 'major new product platform,' says William Blair
William Blair believes Intuitive Surgical's just launched da Vinci Xi robot is a "major new product platform." After attending the Society of American Gastrointestinal and Endoscopic Surgeons meeting, the firm says the clinical reaction to the product is "compelling." It raised its estimate of the total addressable market for Intuitive procedures by 44% and keeps an Outperform rating on the stock.
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use